An electronic nose in the discrimination of breath from smokers and non-smokers: a model for toxin exposure

Exhaled breath contains hundreds of volatile organic compounds (VOCs) that may be used as non-invasive markers of lung disease. Electronic noses (e-noses) can analyse VOCs by composite nanosensor arrays with learning algorithms. This study investigated the use of an e-nose (Cyranose C320) to distinguish the breath of smokers from that of non-smokers. Smoking and non-smoking subjects exhaled from total lung capacity into a 2 L Tedlar bag and these samples were introduced offline to the e-nose in a random order. Two classes of breath, 'smoker' and 'non-smoker', were established and this model was then cross-validated. Principal component analysis then identified the maximal point of difference between classes. Smellprints of breath from smokers were separated from those of non-smokers (cross-validation value, 95%; Mahalanobis distance, 3.96). Subsequently, 15 smokers (mean age 37.9 ± 4.78 years, FEV(1) 3.15 ± 0.21 L), and 24 non-smokers (add mean age and FEV1 as for smokers) were sampled to revalidate the model. The e-nose correctly identified the smoking status in 37 of the 39 subjects. This demonstrates that the e-nose is simple to use in clinical practice and can differentiate the breath of smokers from that of non-smokers. It may prove to be a useful, non-invasive tool for further breath assessment of exposure to other inhaled noxious substances as well as disease monitoring.

[1]  Deborah H Yates,et al.  Fractional exhaled nitric oxide concentration is increased in asbestosis and pleural plaques , 2006, Respirology.

[2]  P. Mazzone,et al.  Detection of lung cancer by sensor array analyses of exhaled breath. , 2005, American journal of respiratory and critical care medicine.

[3]  P. J. Callahan,et al.  Volatile organic compounds as breath biomarkers for active and passive smoking. , 2002, Environmental health perspectives.

[4]  Sabine Kischkel,et al.  Impact of sampling procedures on the results of breath analysis , 2008, Journal of breath research.

[5]  J. Austin,et al.  Prediction of lung cancer using volatile biomarkers in breath. , 2007, Cancer biomarkers : section A of Disease markers.

[6]  Y. Maehara,et al.  Impact of Smoking Status on the Biological Behavior of Lung Cancer , 2007, Surgery Today.

[7]  B. Buszewski,et al.  Analysis of exhaled breath from smokers, passive smokers and non-smokers by solid-phase microextraction gas chromatography/mass spectrometry. , 2009, Biomedical chromatography : BMC.

[8]  E. Martinelli,et al.  Lung cancer identification by the analysis of breath by means of an array of non-selective gas sensors. , 2003, Biosensors & bioelectronics.

[9]  W. Miekisch,et al.  Diagnostic potential of breath analysis--focus on volatile organic compounds. , 2004, Clinica chimica acta; international journal of clinical chemistry.

[10]  Onofrio Resta,et al.  An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. , 2009, Lung cancer.

[11]  P. Montuschi Review: Analysis of exhaled breath condensate in respiratory medicine: methodological aspects and potential clinical applications , 2007, Therapeutic advances in respiratory disease.

[12]  A. Savitzky,et al.  Smoothing and Differentiation of Data by Simplified Least Squares Procedures. , 1964 .

[13]  P. Kvale,et al.  Smoking and lung cancer survival: the role of comorbidity and treatment. , 2004, Chest.

[14]  Philipp Lirk,et al.  Mass spectrometric profile of exhaled breath—field study by PTR-MS , 2005, Respiratory Physiology & Neurobiology.

[15]  P. Mazzone,et al.  How many ways can we say that cigarette smoking is bad for you? , 2004, Chest.

[16]  Paolo Montuschi,et al.  Indirect monitoring of lung inflammation , 2002, Nature Reviews Drug Discovery.

[17]  D. Yates,et al.  Role of exhaled nitric oxide in asthma , 2001, Immunology and cell biology.

[18]  G. Bell Biomarkers in the Breath Associated with Lung Cancer , 2006 .